Revascularization Strategies in Patients with Diabetes and Acute Coronary Syndromes

[1]  L. Thomas,et al.  Diabetes and Incomplete Revascularisation in ST Elevation Myocardial Infarction. , 2020, Heart, lung & circulation.

[2]  E. Barbato,et al.  Coronary Artery Bypass Grafting or Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease , 2020, Circulation. Cardiovascular interventions.

[3]  Xiaoxia Song,et al.  Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025 , 2020, Scientific Reports.

[4]  P. Austin,et al.  Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease. , 2020, Journal of the American College of Cardiology.

[5]  P. Austin,et al.  Revascularization Strategies for the Treatment of Multivessel Coronary Artery Disease in Patients With Diabetes Mellitus. , 2020, Circulation. Cardiovascular interventions.

[6]  L. Thomas,et al.  Cardiac mortality, diabetes mellitus, and multivessel disease in ST elevation myocardial infarction. , 2020, International journal of cardiology.

[7]  G. Stone,et al.  The Hybrid Coronary Approach for Optimal Revascularization: JACC Review Topic of the Week. , 2020, Journal of the American College of Cardiology.

[8]  L. H. A. Salis,et al.  Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2020, The New England journal of medicine.

[9]  M. Farkouh,et al.  Translating Scientific Evidence Into Clinical Practice: Closing the Loop. , 2019, The Canadian journal of cardiology.

[10]  K. J. Miller,et al.  Examining Coronary Revascularization Practice Patterns for Diabetics: Perceived Barriers, Facilitators, and Implications for Knowledge Translation. , 2019, The Canadian journal of cardiology.

[11]  G. Bisleri,et al.  Long-term outcome of total arterial myocardial revascularization versus conventional coronary artery by-pass in diabetic and non-diabetic patients: A propensity-match analysis. , 2019, Cardiovascular revascularization medicine : including molecular interventions.

[12]  V. Fuster,et al.  Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease. , 2019, Journal of the American College of Cardiology.

[13]  P. Kolh,et al.  Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial , 2019, The Lancet.

[14]  Xiantao Song,et al.  Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes , 2019, Cardiovascular Diabetology.

[15]  Samin K. Sharma,et al.  Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. , 2019, Journal of the American College of Cardiology.

[16]  F. Neumann,et al.  'Ten commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization. , 2019, European heart journal.

[17]  Sidney C. Smith,et al.  Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project , 2018, Cardiovascular Diabetology.

[18]  J. Puskas,et al.  Hybrid coronary revascularization for the treatment of multivessel coronary artery disease. , 2018, Annals of cardiothoracic surgery.

[19]  G. Angelini,et al.  Radial‐Artery or Saphenous‐Vein Grafts in Coronary‐Artery Bypass Surgery , 2018, The New England journal of medicine.

[20]  V. Thourani,et al.  Aortic clamping strategy and postoperative stroke , 2018, The Journal of thoracic and cardiovascular surgery.

[21]  V. Fuster,et al.  Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data , 2018, The Lancet.

[22]  Deepak L. Bhatt,et al.  Do We Need a Trial of DES Versus CABG Surgery in Diabetic Patients With ACS? , 2017, Journal of the American College of Cardiology.

[23]  S. Verma,et al.  Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes. , 2017, Journal of the American College of Cardiology.

[24]  M. Domanski,et al.  Type 1 Diabetes, Coronary Disease Complexity, and Optimal Revascularization Strategy. , 2017, Journal of the American College of Cardiology.

[25]  P. Serruys,et al.  Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome. , 2017, The American journal of cardiology.

[26]  I. Elgendy,et al.  Early Invasive Strategy and In‐Hospital Survival Among Diabetics With Non‐ST‐Elevation Acute Coronary Syndromes: A Contemporary National Insight , 2017, Journal of the American Heart Association.

[27]  J. Ottervanger,et al.  Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction , 2016, Open Heart.

[28]  G. Lemesle,et al.  A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction. , 2016, International journal of cardiology.

[29]  Shengshou Hu,et al.  One-stop hybrid coronary revascularization versus off-pump coronary artery bypass in patients with diabetes mellitus. , 2016, The Journal of thoracic and cardiovascular surgery.

[30]  I. Elgendy,et al.  A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel Disease. , 2016, Journal of interventional cardiology.

[31]  A. Pandey,et al.  Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non–ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry–Get with the Guideli , 2016, Circulation. Cardiovascular quality and outcomes.

[32]  P. Serruys,et al.  Balancing idealism with realism to safeguard the welfare of patients: The importance of Heart Team led decision-making in patients with complex coronary artery disease , 2016, Indian heart journal.

[33]  T. Vassiliades,et al.  Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study. , 2013, Journal of the American College of Cardiology.

[34]  S. Bangalore,et al.  Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes. , 2015, The New England journal of medicine.

[35]  M. Desai,et al.  Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. , 2015, American heart journal.

[36]  E. Ohman,et al.  Surgical Versus Percutaneous Coronary Revascularization for Multivessel Disease in Diabetic Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome: Analysis From the Acute Catheterization and Early Intervention Triage Strategy Trial , 2015, Circulation. Cardiovascular interventions.

[37]  A. Yeung,et al.  Trial of everolimus-eluting stents or bypass surgery for coronary disease. , 2015, The New England journal of medicine.

[38]  C. Terkelsen,et al.  Underuse of an invasive strategy for patients with diabetes with acute coronary syndrome: a nationwide study , 2015, Open Heart.

[39]  T. Vassiliades,et al.  Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. , 2014, American heart journal.

[40]  J. Rutledge,et al.  Coronary artery revascularization in patients with diabetes mellitus. , 2013, Circulation.

[41]  A. Pereira,et al.  Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. , 2013, American heart journal.

[42]  M. Mack,et al.  Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[43]  M. Shishehbor,et al.  Strategies for multivessel revascularization in patients with diabetes , 2013 .

[44]  L. Räber,et al.  Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. , 2012, JAMA.

[45]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[46]  Lawrence A Leiter,et al.  Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes. , 2011, American heart journal.

[47]  P. Serruys,et al.  Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. , 2010, Journal of the American College of Cardiology.

[48]  G. Angelini,et al.  Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.

[49]  Maria Mori Brooks,et al.  A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.

[50]  Christopher P Cannon,et al.  Diabetes and mortality following acute coronary syndromes. , 2007, JAMA.

[51]  B. Gersh.  Clinical Judgment and Treatment Options in Stable Multivessel Coronary Artery Disease: Results From the One-Year Follow-Up of the MASS II (Medicine, Angioplasty, or Surgery Study II) , 2007 .

[52]  B. Gersh,et al.  Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. , 2007, Circulation.

[53]  J. Krieger,et al.  Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II). , 2006, Journal of the American College of Cardiology.

[54]  O. Aslan,et al.  Are complex coronary lesions more frequent in patients with diabetes mellitus? , 2006, The Canadian journal of cardiology.

[55]  J. Núñez,et al.  [Invasive strategy in patients with advanced diabetes and non-ST-segment elevation acute coronary syndrome. Angiographic findings and clinical follow-up. PREDICAR study results]. , 2006, Revista espanola de cardiologia.

[56]  Patrick W Serruys,et al.  Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. , 2005, Journal of the American College of Cardiology.

[57]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[58]  Volkmar Falk,et al.  Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. , 2003, The Annals of thoracic surgery.

[59]  M. di Mauro,et al.  Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. , 2003, The Journal of thoracic and cardiovascular surgery.

[60]  P. Serruys,et al.  Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients , 2001 .

[61]  P. Serruys,et al.  Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Study (ARTS) Trial , 2001, Circulation.

[62]  A. Abacı,et al.  Effect of diabetes mellitus on formation of coronary collateral vessels. , 1999, Circulation.

[63]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.